Acquisitions jump in clinical trial operations in H2
The highest value acquisition in 2021 was the $12.3m acquisition of Vifor Pharma by CSL.
IPO Industry
NuvoAir secures additional $11m Series A raise for clinical trials platform
Veeva bolsters clinical suite with Veracity Logic acquisition
Hunting the unicorns: GlobalData IPO predictions for 2022
Innovation Fund Denmark: attracting investment in clinical trials
BEKHealth receives funds to boost AI clinical research
Australia’s first local Covid-19 vaccine gets funding for Phase I trials
HumanFirst secures funding to support clinical trials at home
